The Holter Recording Box segmentation by application delineates three primary demand drivers. Cardiac monitoring—encompassing inpatient telemetry, outpatient follow‑up, and post‑procedural observation—accounts for roughly 55 % of total sales, reflecting its entrenched role in diagnosing arrhythmias and guiding therapeutic decisions. The ambulatory ECG segment, valued at about 30 % of the market, includes remote patient monitoring programs, home‑based diagnostics, and sports‑medicine assessments, where portability and extended recording periods drive procurement. The remaining 15 % is captured by clinical research applications, such as phase‑II/III cardiac drug trials and academic electrophysiology studies, where high‑resolution data capture and regulatory‑compliant storage are paramount. Together, these application categories shape the overall Holter Recording Box market size, with each sub‑segment’s growth trajectory linked to healthcare policy shifts, telehealth adoption, and R&D investment trends.